Markets:

Overview

News

Currencies

International

Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.4340 -0.0243 (-5.30%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Ensysce Biosciences, Inc. Announces Pricing of $7 Million Public Offering

May 10, 2023

Via ACCESSWIRE

Why Is Ensysce Biosciences (ENSC) Stock Up 50% Today? ↗

May 09, 2023

With Ensysce Biosciences achieving testing success regarding its overdose protection drug, ENSC stock soared on the implications.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 09, 2023

Via Benzinga

Ensysce Biosciences (NASDAQ: ENSC) Successfully Completes Overdose-Protection Study

May 09, 2023

Ensysce Biosciences, Inc. (NASDAQ: ENSC) operates as a clinical-stage biotechnology company, which is focused on leveraging its proprietary technology to

Via Spotlight Growth

Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection

May 09, 2023

Via ACCESSWIRE

Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform Accelerated Development

April 19, 2023

Via ACCESSWIRE

Ensysce Biosciences Announces Updated Investor Presentation Available Via Investor Relations Website

April 11, 2023

Via ACCESSWIRE

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 09, 2023

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.

Via Benzinga

Why Are Ensysce Biosciences Shares Are Trading Higher Today ↗

May 09, 2023

Ensysce Biosciences Inc (NASDAQ: ENSC) completed PF614-MPAR-101, a clinical study examining the company's first pain medication with overdose protection,

Via Benzinga

Ensysce Biosciences's Return On Capital Employed Overview ↗

April 03, 2023

Via Benzinga

Ensysce Biosciences Announces Positive Results from Oral Human Abuse Potential Trial for PF614

April 03, 2023

Via ACCESSWIRE

Ensysce Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results

March 30, 2023

Via ACCESSWIRE

Ensysce Biosciences Announces Completion of Enrollment for Groundbreaking Opioid Overdose Protection Study

March 22, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 09, 2023

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Dr. Lynn Kirkpatrick, Featured Speaker to Discuss Ensysce Overdose Protection Platform at DCAT Seminar

March 06, 2023

Via ACCESSWIRE

Ensysce Biosciences Announces Critical Step in Human Abuse Potential Study of PF614 With Database Lock

February 28, 2023

Via ACCESSWIRE

Ensysce Biosciences Provides Corporate Update

February 23, 2023

Via ACCESSWIRE

Stocks That Hit 52-Week Lows On Monday ↗

April 03, 2023

On Monday, 76 companies set new 52-week lows.

Via Benzinga

Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday ↗

March 31, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 31, 2023

Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.

Via Benzinga

Ensysce Biosciences And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

March 07, 2023

The Dow Jones rose around 40 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny...

Via Benzinga

ObsEva, Ensysce Biosciences And 2 Other Stocks Under $1 Insiders Are Aggressively Buying ↗

March 03, 2023

The Dow Jones jumped by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 28, 2023

During Tuesday, 79 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 15, 2023

Via Benzinga

Ensysce Biosciences Receives Positive Nasdaq Listing Determination

February 15, 2023

Via ACCESSWIRE

Ensysce Biosciences to Present its Overdose Protection Program at the 4th Annual NIH 'HELPING END ADDICTION LONG-TERM' (HEAL) Meeting

February 14, 2023

Via ACCESSWIRE

Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules

February 07, 2023

Via ACCESSWIRE

Ensysce Biosciences, Inc. Announces $3 Million Registered Direct Offering

February 03, 2023

Via ACCESSWIRE

Over $12 Million Bet On TD Holdings? Check Out These 3 Penny Stocks Insiders Are Buying ↗

February 02, 2023

The Federal Reserve on Wednesday raised its benchmark rate by 0.25%, marking the central bank's second consecutive policy downshift. When insiders purchase or sell shares, it indicates their confidence...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.